Author

Yoshimi Miki

Center for Disease Biology and Integrative Medicine, The University of TokyoORCID 0000-0002-8587-0333Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Ai KotaniiD· 1 shared Atsushi Irie· 1 shared Chika Mochizuki-Ono· 1 shared Jerold J. M. ChuniD· 1 shared Junken AokiiD· 1 shared Kai KudoiD· 1 shared Kazuharu HanadaiD· 1 shared Kosuke HataiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ai KotaniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Secreted phospholipase PLA2G12A-driven lysophospholipid signaling via lipolytic modification of extracellular vesicles facilitates pathogenic Th17 differentiation

Chika Mochizuki-Ono, Yoshitaka Taketomi, Atsushi Irie, Kuniyuki Kano, Yuki Nagasaki, Yoshimi Miki, Takashi Ono, Yasumasa Nishito, Takahiro Nakajima, Yuri Tomabechi, Kazuharu Hanada, Mikako Shirouzu, Takashi Watanabe, Kosuke Hata, Yoshihiro Izumi, , Makoto Murakami

This study identifies PLA2G12A's role in Th17 differentiation through lysophospholipid signaling via extracellular vesicles, showing therapeutic potential for Th17-related diseases.

Cell Reports · Jun 1, 2026Peer-reviewedImmunology